Beckman Coulter/Princeton BioMeditech agreement
In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter has entered into a supply relationship with Princeton BioMeditech (PBM). Under the agreement, PBM will supply a wide range of rapid diagnostic tools used at the point of medical care to Beckman Coulter's Primary Care Diagnostics business unit (PCD).
Princeton BioMeditech is a leading innovator and manufacturer of simple and rapid diagnostic products used at the point of care. The company offers more than 70 tests covering fertility management, infectious diseases, cardiac markers, drugs of abuse, cancer markers, environmental and veterinary diagnostics that enable consumers and professionals to improve speed and quality of diagnosis for better patient care.
Women in STEM Ambassador initiative wound up
The Australian Government has announced that the functions of the Women in STEM Ambassador will...
Australian Research Council awards 58 new Industry Fellowships
The ARC's Industry Fellowship Program aims to promote national and international...
CUREator+ to fund innovations in dementia, cognitive decline
The CUREator+ Dementia and Cognitive Decline incubator program aims to support novel approaches...
